What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?
Open Access
- 21 July 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 26 (21) , 2269-2276
- https://doi.org/10.1093/eurheartj/ehi410
Abstract
Aims To define the N-terminal pro-brain natriuretic peptide (NTpBNP) normal range, assessing its cardiovascular screening characteristics in general population and higher risk subjects. Methods and results A total of 2320 subjects (1392 general population and 928 high-risk) ≥45 years old, selected randomly from seven community practices, were invited to undergo clinical assessment and echocardiography and to assess NTpBNP serum levels. Of these, 1205 attended. The NTpBNP normal range was calculated and its cardiovascular screening characteristics were assessed. Age (PPConclusion Normal NTpBNP levels should be stratified by age and gender. Normal NTpBNP levels give high NPV in excluding significant cardiovascular disease. Most subjects with raised NTpBNP levels and almost all subjects with NTpBNP levels over four times the normal have significant cardiovascular disease.Keywords
This publication has 30 references indexed in Scilit:
- Analytical performance of the N terminal pro B type natriuretic peptide (NT‐proBNP) assay on the Elecsys™ 1010 and 2010 analysersEuropean Journal of Heart Failure, 2004
- NT‐proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studiesEuropean Journal of Heart Failure, 2004
- Biochemical indicators of cardiac and renal function in a healthy elderly populationClinical Biochemistry, 2003
- B-type natriuretic peptide in cardiovascular diseaseThe Lancet, 2003
- Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based studyThe Lancet, 2001
- How to diagnose diastolic heart failureEuropean Heart Journal, 1998
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairmentClinical Endocrinology, 1997
- An Introduction to the BootstrapPublished by Springer Nature ,1993
- Recommendations for Quantitation of the Left Ventricle by Two-Dimensional EchocardiographyJournal of the American Society of Echocardiography, 1989
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsPublished by Elsevier ,1986